FDA

Some of the best links we picked up around the internet

Regulators fast-track gene editing for neonatal...

Jan. 21, 2026

iECURE's ECUR-506 has secured both the US FDA Regenerative Medicine Advanced Therapy designation and a UK Innovation Passport, positioning the...

CMN Weekly (16 January 2026) - Your Weekly CRISPR...

CMN Weekly

Jan. 16, 2026

Some of the best links we picked up around the internet

Therapeutic Gene Editing. A Lot Done, a Lot More...

CMN Interview

Feb. 5, 2024

For the inaugural episode of CMN Live on 26th January 2024, we spoke with Eric Kmiec, Ph.D. about the successes of therapeutic gene editing to date,...

CMN Weekly (2 February 2024) - Your Weekly CRISPR...

CMN Weekly

Feb. 2, 2024

Some of the best links we picked up around the internet

Intellia Therapeutics Gets FDA Green Light to...

Mar. 15, 2023

Intellia Therapeutics recently announced that the FDA has cleared an Investigational New Drug application for NTLA-2002, a single-dose in vivo CRISPR...

Clinical update: FDA Upgrades Status for Two...

Mar. 16, 2022

This week's update includes news about two gene-edited therapies for cancer. Allogene Therapeutics' ALLO-316 has been granted Fast Track Designation...

CARBON Newsletter (8 March 2022) - Your Latest...

Carbon

Mar. 8, 2022

Some of the best links we picked up around the internet